Related Experiment Video

Updated: Oct 1, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

An unusual presentation of metabolic cardiomyopathy due to Pompe's disease

Poothirikovil Venugopalan1, Shakeel Ahmed, Vasudev T Rao

  • 1Department of Child Health, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman. gopalax@omantel.net.com

Saudi Medical Journal
|April 9, 2002
PubMed

Insights

A case study reports an Omani infant with cardiac failure due to hypertrophic cardiomyopathy, later diagnosed with Type II glycogenosis (Pompe disease), a metabolic disorder. The study outlines differential diagnosis and management strategies for metabolic cardiomyopathy.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Cardiology

Background:

  • Hypertrophic cardiomyopathy in neonates can be a sign of underlying metabolic disorders.
  • Early diagnosis and management are crucial for improving outcomes in infants with metabolic cardiomyopathies.
  • Glycogen storage diseases, such as Pompe disease, can present with cardiac manifestations.

Observation:

  • A case of an Omani infant boy presenting with neonatal cardiac failure attributed to hypertrophic cardiomyopathy.
  • The infant later developed multisystem involvement, indicative of a progressive metabolic disorder.
  • Clinical progression led to the diagnosis of Type II glycogenosis (Pompe disease).

Findings:

  • Type II glycogenosis (Pompe disease) can manifest as severe hypertrophic cardiomyopathy in the neonatal period.
  • Multisystem involvement is a characteristic feature of advanced Pompe disease.
  • Accurate diagnosis requires a comprehensive approach considering both cardiac and systemic symptoms.

Implications:

  • This case highlights the importance of considering metabolic disorders in the differential diagnosis of neonatal hypertrophic cardiomyopathy.
  • Understanding the presentation and progression of Pompe disease is vital for pediatric cardiologists and metabolic specialists.
  • Effective management strategies for metabolic cardiomyopathy can improve patient prognosis and quality of life.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...